PRICE T ROWE ASSOCIATES INC /MD/ - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 219 filers reported holding NPS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$17,100,000
+32.3%
478,065
-3.8%
0.00%
+33.3%
Q3 2014$12,927,000
-20.4%
497,200
+1.2%
0.00%
-25.0%
Q2 2014$16,237,000
+16.1%
491,300
+5.1%
0.00%
+33.3%
Q1 2014$13,989,000
-49.5%
467,400
-48.8%
0.00%0.0%
Q4 2013$27,700,000
+270.2%
912,400
+287.9%
0.00%
+50.0%
Q3 2013$7,482,000
+31.4%
235,200
-37.6%
0.00%
+100.0%
Q2 2013$5,696,000377,2000.00%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 424,175$12,695,0005.06%
Opaleye Management Inc. 150,000$4,490,0003.32%
OAK RIDGE INVESTMENTS LLC 2,795,331$83,664,0002.10%
SCHOLTZ & COMPANY, LLC 60,350$1,806,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,408,729$42,163,0001.73%
First Light Asset Management, LLC 79,099$2,367,0001.68%
FCG ADVISORS, LLC 71,146$2,129,0001.51%
Rhenman & Partners Asset Management AB 166,970$4,997,0001.50%
BENDER ROBERT & ASSOCIATES 73,611$2,203,0001.48%
Eventide Asset Management 283,900$8,497,0001.32%
View complete list of NPS PHARMACEUTICALS INC shareholders